Skip to main content

Table 2 Three proportional hazards models of mortality as a function of time with stepwise addition of variables

From: Renal function at the time of a myocardial infarction maintains prognostic value for more than 10 years

 

0-2 years

 

2-4 years

 

4-6 years

 

6-8 years

 

8-10 years

 

10-12 years

 

12-14 years

 

14-16 years

 

16-years

 
 

N = 6676

 

N = 4702

 

N = 4022

 

N = 3474

 

N = 2978

 

N = 2526

 

N = 2152

 

N = 1854

 

N = 1576

 

Variables

RR

CI*

RR

CI*

RR

CI*

RR

CI*

RR

CI*

RR

CI*

RR

CI*

RR

CI*

RR

CI*

Model 1

                  

eGFRgroup**

1.77

1.69-1.85

1.57

1.46-1.70

1.45

1.33-1.58

1.43

1.30-1.56

1.53

1.39-1.68

1.42

1.27-1.58

1.40

1.24-1.58

1.36

1.20-1.55

1.28

1.04-1.57

Cregroup

2.09

1.96-2.23

1.95

1.71-2.22

1.89

1.61-2.21

1.58

1.30-1.91

1.68

1.36-2.06

1.51

1.17-1.95

1.55

1.14-2.10

0.91

0.63-1.33

1.57

0.93-2.63

Model 2***

                  

Male gender

1.11

1.00-1.24

1.45

1.22-1.73

1.12

0.92-1.36

1.36

1.10-1.67

1.22

0.98-1.51

1.83

1.41-2.37

1.15

0.88-1.50

1.22

0.92-1.61

1.01

0.66-1.55

Age****

1.37

1.29-1.45

1.64

1.50-1.81

1.66

1.50-1.84

1.86

1.66-2.06

1.86

1.66-2.08

1.91

1.69-2.18

1.95

1.69-2.24

1.90

1.63-2.20

2.10

1.66-2.67

eGFRgroup**

1.27

1.20-1.34

1.21

1.11-1.32

1.12

1.01-1.23

1.10

0.99-1.22

1.20

1.07-1.34

1.19

1.05-1.35

1.11

0.96-1.29

1.13

0.97-1.31

1.01

0.79-1.29

Cregroup

1.34

1.24-1.46

1.30

1.12-1.51

1.47

1.24-1.74

1.10

0.90-1.36

1.30

1.05-1.63

1.25

0.96-1.62

1.28

0.93-1.76

0.76

0.52-1.11

1.35

0.79-2.32

eGFRgroup 2 vs. 1

1.15

0.98-1.36

0.86

0.68-1.08

0.88

0.69-1.12

1.10

0.86-1.41

0.92

0.71-1.20

1.06

0.81-1.38

0.87

0.64-1.17

1.08

0.80-1.45

0.89

0.57-1.38

eGFRgroup 3 vs. 1

1.48

1.26-1.75

1.04

0.82-1.33

1.10

0.85-1.41

0.89

0.67-1.18

1.29

0.98-1.69

1.30

0.96-1.76

1.10

0.78-1.53

1.09

0.76-1.56

0.81

0.46-1.42

eGFRgroup 4 vs. 1

1.97

1.65-2.35

1.72

1.32-2.24

1.35

0.99-1.84

1.71

1.23-2.37

1.68

1.16-2.42

1.84

1.20-2.83

1.58

0.96-2.59

1.92

1.13-3.26

1.89

0.78-4.55

  1. In all models either cregroup or eGFR were included in the model.
  2. *95% confidence interval
  3. **Hazard ratio associated with 1 eGFR group improvement
  4. ***Other covariates in model 2: Body mass index, previous AMI, angina pectoris, congestive heart failure, diabetes mellitus, wall motion index, systemic hypertension, thrombolytic therapy.
  5. ****Hazard ratio associated with an increase in age of 10 years.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us